Status:
COMPLETED
GSK BHR Study (Sont)
Lead Sponsor:
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
The purpose of this study was to determine whether asthma control and reduced bronchial hyperresponsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISK...
Eligibility Criteria
Inclusion
- Asthma diagnosis
- Controller medications or moderate inhaled corticosteroid dose
- Evidence of reversibility
Exclusion
- Life-threatening asthma
- Asthma instability
- Concurrent respiratory disease
- Drug allergy
- Respiratory tract infection
- Systemic corticosteroid use
- Immunosuppressive medication use
- Positive pregnancy test
- Tobacco use
- Site affiliation
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2004
Estimated Enrollment :
464 Patients enrolled
Trial Details
Trial ID
NCT00920543
Start Date
February 1 2003
End Date
October 1 2004
Last Update
September 1 2016
Active Locations (58)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Birmingham, Alabama, United States, 35209
2
GSK Investigational Site
Phoenix, Arizona, United States, 85006
3
GSK Investigational Site
Tucson, Arizona, United States, 85712
4
GSK Investigational Site
Carmichael, California, United States, 95608